Greta Garrido

Greta Garrido

Company: Nurix Therapeutics

Job title: Associate Director


Panel Discussion: Addressing the Key Challenges for Potency Assay Strategies for TIL Candidates 1:30 pm

• Discussing tumor specific vs. tumor-antigen specific assays and ideal tumor target material • Addressing the need for robust, reliable and reproducible assays for TIL therapies • TIL is a complex, patient-specific therapy, including product variability against unknown antigen specificityRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.